{
    "id": "dbpedia_461_0",
    "rank": 55,
    "data": {
        "url": "https://sts2023.saudithoracicsociety.org/international-speakers/",
        "read_more_link": "",
        "language": "en",
        "title": "International Speakers",
        "top_image": "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/02/favicon.png",
        "meta_img": "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/02/favicon.png",
        "images": [
            "https://sts2023.saudithoracicsociety.org/wp-content/themes/incubator/core/assets/images/logo.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/themes/incubator/core/assets/images/logo-2.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Prof.-Darcy-D.-Marciniuk-300x300.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-Pamela-J.-McShane-MD-300x300.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Prof-Jordi-Relio-300x300.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Dr.-Masahide-Oki-MD-FCCP-300x300.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Dr-Eril-Folch-300x300.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Prof.-Elena-Bargagli-300x300.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-Marcos-I.-Restrepo-MD-MSc-PhD-300x300.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-Anjali-Vaidya-MD-FACC-FASE-FACP-300x300.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Dr.-John-Goffin-MD-FRCPC-300x300.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Prof.-Burton-F.-Dickey-300x300.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Dr.-Paolo-Spagnolo-MD-PhD-300x300.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-Anke-Hilse-Maitland-van-der-Zee-MSc-PharmD-PhD-2x-300x300.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-David-M.-Rapoport-MD-300x300.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Prof.-John-Hanrahan-300x300.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-Christian-Finley-MD-MPH-FRCSC-300x300.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Pierluigi-Paggiaro-300x300.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Roberto_Badagliacca-300x300.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-Cori-L-Daines-MD-300x300.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Dr.-Stephen-C-Mathai-MD-MHS-FCCP-300x300.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Dr.-Roberto-Tonelli-MD-PhD-300x300.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-Demosthenes-Bouros-MD-PhD-FERS-FAPSR-FCCP-300x300.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Dr.-Elliot-Ho-DO-300x300.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Federico-Lavorini-300x300.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Richard-Gisli-Jenkins-300x300.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Hajar_MAl_Hayyan-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Nashmia_Almutairi-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Roberto_Badagliacca-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Hussein-S.-Al-Juwayed-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Doaa-Gad-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Shaden-Qasrawi-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Bashayr-Alotaibi-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Wael-Albalawy-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Fatmah-Alhabeeb-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Rayyan-M.-ALMusally-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Fahad-Alobaid-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Kaine-Teme-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Mohmmed-A.-Algamdi-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Lamia-G.-Jamjoom-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Sultan-A.-Qanash-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Dr.-Noura-Alturaif-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Dr.-Waleed-Alharbi-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/10/Rand-Arnaout-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Richard-Gisli-Jenkins-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Federico-Lavorini-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Pierluigi-Paggiaro-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/DrHatoonBakhribah-150x150.jpeg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/AliAlbarrk-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Dr-Waleed-Saleh-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Prof-Khalid-Alkattan-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Dr-Ahmed-Alshehri-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/DrSamiAlhaider_pic-copy-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Dr-Riyad-Al-Lehebi-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Dr-Hussam-Adi-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Prof.-Waseem-HAJJAR-Photo-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Dr-Khalid-F.-Al-Mobaireek-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Dr-Faris-Alhejaili-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Prof.-Mark-Metersky-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Dr.-Catherine-L.-Oberg-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Prof.-Leonardo-M.-Fabbri-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Prof.-John-Hanrahan-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Prof.-Burton-F.-Dickey-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Prof.-Elena-Bargagli-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Dr-Eril-Folch-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Prof-Jordi-Relio-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Prof.-Darcy-D.-Marciniuk-150x150.png",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Hussam-Sakkijha-MD-1-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Hani-Lababidi-MD-FCCP-FACP-FSSH-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Ahmed-Jamjoom-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/09/Mohamed-S.-Al-Hajjaj-MD-FRCPC-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Fahad-A.-ALmugbel-MBBS-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Fahad-Ibnshamsah-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Waleed-Alselwi-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Abdulraheem-Alshangiti-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Abdullah-A.-Al-Sharm-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Ahmed-Alwbari-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Ahmed-Abdulaziz-Aljohaney-MBBS-DABIM-FRCPC-1-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Esam-M.-Murshid-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Kanaan-Al-Shammari-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Mohammed-A.-Algarni-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Waleed-A.-Alghareeb-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Ali-Aljubran-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Mohammed-Alghamdi-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Shouki-Bazarbashi-MBBS-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Majed-Alghamdi-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Safwan-A.-Bakhsh-MBBCh-ABIM-FRCPC-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Fadi-S.-Aljamaan-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Abdullah-Alshimemeri-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Mohamed-Zeitouni-MD-FCCP-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Muhannad-Hawari-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Mervat-Mahrous-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Mohammed-Alhajji-MD-MSc-FRCP-London-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Ahmed-Refae-MBBCh-MSc-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Ahmed-S.-Al-Enezi-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Bader-J.-Alghamdi-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Marwan-Al-Hejili-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Ameen-S.-Al-Omair-MD-FRCPC-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Waleed-A.-AlSowayan-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Abdullah-K.-Altwairgi-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Adel-S.-Alharbi-MD-FCCP-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Ashwaq-B.-Alshareif-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Shadi-S.-Alkhayyat-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Enas-Mansour-Batubara-MD-SB-IM-SF-AP-FCCP-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Abdullah-F.-Al-Mobeireek-FRCP-FCCP-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Muath-A.-ALNassar-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Hamdan-Al-Jahdali-MD-FRCPC-FCCP-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-Anke-Hilse-Maitland-van-der-Zee-MSc-PharmD-PhD-1x-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Shareefah-M.-Basheri-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Mohammed-Al-Ghobain-MD-MPH-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Nuha-Alrajhi-MBBS-SB-MED-ABIM-KSUF-MED-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Nizar-M-Yamani-MBBS-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Ranya-A-Alshumrani-MBBS-FAAP-FAASM-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Medhat-M.-Bukhari-MBChB-FRCSC-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Majdy-Idrees-MD-FRCPC-FCCP-FPVRI-FRCP-Edin-Hon-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Turki-S.-Alahmadi-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Ahmed-Almotiri-MD-RRT-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Siraj-O.-Wali-MBBS-FRCPC-FACP-FCCP-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Turki-Al-Faye-MD-ABIM-FRCPC-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Hamed-Al-Husaini-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Tarek-Kashour-MD-FRCPC-FACC-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Samah-Alrehaily-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Saleh-N.-Abu-Daff-MBBS.-MRCS-UK-1-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Suha-K.-Kaaki-MBBS-FRCSC-FACS-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Yaseen-Arabi-MD-FCCP-FCCM-ATSF-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Mohamed-S.-Al-Moamary-ABIM-FRCPEdin-MBA-LS-FCCP-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Hatem-O.-Qutub-MD-FCCP-FCCM-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Ahmed-Allehebi-MBBS-FRCPC-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Esam-H.-Alhamad-MD-FACP-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-Pamela-J.-McShane-MD-1-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-Carmine-Dario-Vizza-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Dr.-Elliot-Ho-DO-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-Demosthenes-Bouros-MD-PhD-FERS-FAPSR-FCCP-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Dr.-Roberto-Tonelli-MD-PhD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Dr.-Stephen-C-Mathai-MD-MHS-FCCP-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-Cori-L-Daines-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-Christian-Finley-MD-MPH-FRCSC-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-David-M.-Rapoport-MD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-Konstantinos-Kostikas-MD-PhD-FCCP-FERS-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Dr.-Paolo-Spagnolo-MD-PhD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Dr.-John-Goffin-MD-FRCPC-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-Anjali-Vaidya-MD-FACC-FASE-FACP-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Prof.-Marcos-I.-Restrepo-MD-MSc-PhD-150x150.jpg",
            "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/08/Masahide-150x150.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": "2023-08-10T18:04:59+00:00",
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "https://sts2023.saudithoracicsociety.org/wp-content/uploads/2023/02/favicon.png",
        "meta_site_name": "sts2023",
        "canonical_link": "https://sts2023.saudithoracicsociety.org/international-speakers/",
        "text": "Dr. Roberto Badagliacca is an associate professor of cardiology at Sapienza University of Rome.\n\nMy research focus during and following my medical training has been on pulmonary arterial hypertension. I received advanced clinical and research training in cardiovascular diesease, cardiovascular imaging, and advanced heart failure. Since my appointment as Associate Professor of Cardiology, I have developed a specific interest in studying the pathophysiology, imaging phenotyping and risk stratification of pulmonary arterial hypertension. My research experience has culminated in the inclusion in the Nucleus of the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, in a variety of peer-reviewed publications in the area and the inclusion as a Task Force Member of important Guidelines and Consensus documents Committees:\n\nGuidelines for the “Diagnosis and Treatment of Pulmonary Hypertension” for the European Society of Cardiology and European Respiratory Society (2020-2022); Consensus Statement on “Peri-operative Management of Patients with Pulmonary Hypertension and Right Heart Failure Undergoing Surgery” for the International Society of Heart and Lung Transplantation (2020-2022); Consensus Statement on “Risk Stratification in Pulmonary Arterial Hypertension” for the International Society of Heart and Lung Transplantation (2022).\n\nFederico Lavorini is a Professor of Respiratory Medicine and Head of the Respiratory and Critical Care Unit at the Department of Clinical and Experimental Medicine, University of Florence, Italy. He qualified in Medicine at the University of Florence (1991), has the Specialist Certification in Respiratory Medicine (1996), and he also undertook a Ph.D. board certified in Respiratory Pathophysiology (2000).\n\nHis research interests are cough pathophysiology and aerosol medicine, particularly the study of effectiveness of inhaler devices and their use by asthma and COPD in a real-life setting. Since 2022, Federico Lavorini has published over 150 peer-reviewed papers and 80 of them are in the field of aerosol medicine. He has extensive experience in both academic and industrial pharmaceutics, and still retains a strong link with the pharmaceutical industry.\n\nRecently, he patented a powder formulation of an antitussive drug deliverable by means of a capsule-based dry powder inhaler. Federico Lavorini is a member of the Aerosol Drug Management Improvement Team (ADMIT), an european consortium of respiratory physician with special interests in aerosol medicine.\n\nFederico Lavorini is Chairman of the Italian Respiratory Society (SIP) Taskforce on aerosol delivery systems; he was also Co-Chair of the Global Consortium of Standards for Inhaler Errors, an initiative by the Imperial College London, UK. Federico Lavorini is Associate Editor and Review Editor of the Respiratory Physiology and Pathophysiology, Frontiers in Physiology, and Canadian Respiratory Journal. Federico Lavorini acts as board member of the Journal of Aerosol Medicine and Pulmonary Drug Delivery and he is a contributor and reviewer for the Journal.\n\nFederico Lavorini presented several invited lectures on aerosol medicine topics in international meetings of the European Respiratory Society, American Thoracic Society, International Society of Aerosol Medicinea, RDD and DDL amomg others.\n\nFull Professor of Respiratory Medicine at the University of Pisa from 2007 to 2018 and Chief of the Respiratory Pathophysiology and Pulmonary Rehabilitation Unit of the University Hospital of Pisa. Graduated in Medicine and Surgery at the University of Pisa in 1972, He post-graduated in Occupational Medicine (1974), Respiratory Medicine (1977) and Allergy and Clinical Immunology (1981). Post-doctoral fellowships at the University of British Columbia (Vancouver, Canada, 1985 and 1987) and at the S. Francisco General Hospital (S. Francisco, Ca, USA, 1989).\n\nThe research fields include: pathophysiology and therapy of asthma and COPD, occupational asthma, airway pharmacology, pulmonary rehabilitation, COPD and bronchiectasis. He was the Principal Investigator of several phase 2-phase 3 clinical trials in asthma and COPD, and Principal Investigator of several research projects funded by Italian Ministry of Health, Italian Agency of the Drug (AIFA), Tuscany Region and pharmaceutical companies. He is component of the Steering Committee of the Italian Network on Severe Asthma (SANI) and of the Steering Italian Committee of the Precision International Project.\n\nFrom 2005 to 2014, He was member of the Board of Directors of GINA International, and Chairman of the GINA Mediterranean Initiative. Since 2005 He is the chairmen of the GINA Italy Initiative. In 2016 He was nominated as Fellow of European Respiratory Society\n\nHe is author or co-authors of more than 330 manuscripts published on peer-review international journals (see PubMed) on asthma, COPD and bronchiectasis.\n\nDr. Mark L. Metersky, MD, FCCP is a Professor of Medicine at the University of Connecticut School of Medicine where he serves as the Chief of Service for the Department of Medicine, Chief of the Division of Pulmonary, Critical Care and Sleep Medicine and Director of UCONN Center for Bronchiectasis Care.\n\nHe is a graduate of the New York University School of Medicine, then went on to train in Internal Medicine at Boston City Hospital and then in Pulmonary and Critical Medicine at the University of California, San Diego Medical Center.\n\nDr. Metersky has long standing interest in pulmonary infections, including pneumonia and bronchiectasis and has over 150 publications and has presented extensively on these subjects. He serves as the Chair of the COPD Foundation-sponsored United States Bronchiectasis and NTM Research Registry.\n\nHe serves as an ad hoc reviewer for over 20 journals, and is on the Editorial Board of CHEST. He was the American Thoracic Society Co-Chair of the writing panel for the “Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society” and was a co-author of the 2019 ATS/IDSA Community-Acquired Pneumonia Guidelines.\n\nDr. Catherine Oberg is an Interventional Pulmonologist in Los Angeles, California. She completed medical school at the University of Tennessee (her home state), residency training in Internal Medicine at the University of Southern California (USC) in Los Angeles, Pulmonary/Critical Care fellowship training at the Icahn School of Medicine at Mount Sinai in New York City, NY, and Interventional Pulmonology advanced fellowship training at the Harvard Combined Program (Beth Israel Deaconess Medical Center/Massachusetts General Hospital) in Boston. She has since been in practice at the University of California, Los Angeles (UCLA) where she is the Director of Interventional Pulmonology, South Bay, and the Program Director for the Interventional Pulmonology fellowship.\n\nShe is interested in advancing Interventional Pulmonology clinical practice through research and education. She routinely gives regional, national, and international lectures on robotic/navigational bronchoscopy, complex airway disease, pleural disease, and esophageal procedures. She has also published multiple peer-reviewed articles and book chapters on various topics related to IP. She is a reviewer for multiple medical journals and has been voted as a Top Reviewer for the Annals of Internal Medicine three years in a row. She was also voted as a Super Doctor, Rising Star for 2022 and 2023.\n\nShe is an avid traveler and has visited over 30 countries. She enjoys medical volunteer work which she has done in Tanzania, India, and Haiti as well as in her local communities in Memphis, New York, and Los Angeles. She is honored to be a part of the Saudi Thoracic Society 2023 International Conference!\n\nLeonardo M. Fabbri was Professor and Director of Internal Medicine and of Respiratory Medicine at the University of Modena and Reggio Emilia until 2016. Then he became and still is Eminent Scholar of Respiratory and Internal Medicine at the University of Ferrara. He served as Associate Editor in some of the most important Respiratory Journals (AJRCCM, Lancet Resp Med, Eur Respir J), and continues to serve as reviewers for the same journals and journals of internal medicine.\n\nHe was one of the founding partners of the Global Initiative on Asthma (GINA) and Global Initiative on Obstructive Lung Disease (GOLD). He was President of the European Respiratory Society (ERS) (2007-2008).\n\nHis main areas of interest have been and still are asthma, COPD and chronic multimorbidity. He has published > 600 papers in peer reviewed journals plus several book chapters. His Hirsh Index March 2023 are 127 according to Google Scholar and 107 according to Scopus.\n\nDr. Hanrahan received his PhD from the University of British Columbia and completed post-doctoral studies at Yale Univ. Sch. Medicine from supported by fellowships from NSERC/NATO and the Medical Research Council of Canada. At Yale he carried out noise analysis and patch clamp studies of anion channels in the rabbit urinary bladder epithelium. In 1986 he was recruited to the Department of Physiology at McGill University where he was supported as an FRQS Chercheur Boursier, and by MRC Scholar, Scientist and Senior Scientist awards.\n\nHe is currently professor of Physiology, founding director of the Cystic Fibrosis Translational Research centre (CFTRc), and associate member of the Meakins-Christie Laboratories and the Research Institute of the McGill University Health Centre. He is co-founder of Traffick Therapeutics, a Montreal-based spin-off company. He has extensive international collaborations and recently completed an E-rare project (INSTINCT) with groups in Germany, Italy, The Netherlands, Portugal and Canada.\n\nHe currently serves on a scientific advisory board for a Strategic Research Centre sponsored by the UK CF Trust. After establishing a laboratory at McGill, Dr. Hanrahan helped to identify the anion channel that is defective in cystic fibrosis (CF), which was subsequently named CFTR, and helped establish that the defective gene encodes that channel. He studied its permeation properties, regulation of CFTR by kinases and phosphatases, and demonstrated that it is initially stimulated and then inhibited by exposure to cigarette smoke. His laboratory is currently focused on understanding acquired CFTR deficiency in COPD, the role of pulmonary ionocytes in pH and bicarbonate regulation on the airway surface, and delivery of therapeutics to the lungs using novel polymeric nanoparticles.\n\nDr. Jordi Rello earned with honours his Medical Degree (1985) and PhD in Infectious Diseases (1990) at University of Barcelona, Spain, completing a residence/fellowship in Critical Care (1990) in Hospital Sant Pau in Barcelona. Dr Rello get additional training in infection control and ID epidemiology at Harvard Medical School, Boston.\n\nCurrently, he is Full Professor of Medicine at Universitat Internacional de Catalunya, Barcelona, Spain and Director of the Clinical Research/Innovation in Pneumonia and Sepsis (CRIPS) Group at Vall d’Hebron Research Institute & CIBERES, ubicated in Vall d’Hebron Barcelona Hospital Campus.\n\nHe has conducted clinical practice as consultant, leaded research and trained fellows in critical care from 1990, with special focus on severe pneumonia & precision medicine in sepsis. After serving as critical care consultant in Hospital Clinic de Barcelona & Hospital Tauli in Sabadell, Dr Rello become Head of the ICU Department in 1999 in the University Hospital de Tarragona and in 2000 at the University Hospital Vall d’Hebron, Barcelona.\n\nHe has directed above 20 doctoral thesis, being part of his academic duties as Professor of Medicine at the Universitat Autònoma de Barcelona and Rovira & Virgili University in Tarragona.\n\nProf. Rello has > 630 indexed manuscripts with above 50,000 citations (overall 2,850 per year from 2013), an H-index of 117.\n\nDr. Pamela McShane was born and raised in Chicago. She attended Loyola University of Chicago for her undergraduate studies in Biology and went on to attend Loyola University Stritch School of Medicine. During fellowship training in pulmonary and critical care medicine at the University of Chicago, Dr. McShane developed a clinical and research interest in bronchiectasis and nontuberculous mycobacteria (NTM) lung disease.\n\nShe developed a Chicago based clinical and research registry for bronchiectasis patients and later joined the U.S. Bronchiectasis and NTM Research Registry. Dr. McShane went on to work at the U.S. National Institutes of Health in Bethesda, Maryland where she focused on NTM infection in bronchiectasis patients. In 2020, Dr. McShane moved to the University of Texas Health Science Center in Tyler, Texas which houses a world-renowned acid-fast bacteria laboratory.\n\nShe is medical director of the Bronchiectasis and NTM Pulmonary Institute at the University of Texas Health Science Center at Tyler. She is primary investigator for approximately a dozen clinic trials and she also serves as associate editor for CHEST and the Journal of Clinical Tuberculosis and Other Mycobacteria.\n\nDr. Demosthenes Bouros is emeritus professor of Pneumonology at the National and Kapodistrian University of Athens, Medical School, Greece. He started his academic career as assistant Professor of Pneumonology (1989) and associate Professor (1995-2002), at the Medical School, University of Crete, and Professor of Pneumonology at the Democritus University of Thrace, Greece (2002-2014), and Professor of Pneumonology at the National and Kapodistrian University of Athens, Greece (2014-2019). He was trained at Harvard and Boston Universities, USA, and the Royal Brompton Hospital, UK. He warded as visiting professor at the Medical University of Vienna by the European Respiratory Society (ERS).\n\nClinical Experience: Since 2019 is head of the department of respiratory diseases and the ILDU unit of the Athens Medical Center, Athens, Greece. Previous posts: head of Respiratory disease departments: 401 Army General Hospital, Athens (1984-1986 and 1988-1990); vice director Dept. of Thoracic Medicine, University hospital of Crete (1990-2002); director Dept. of Respiratory Medicine, University hospital of Alexandroupolis (2002-2014); head of ILD unit, Hospital for Diseases of the Chest ‘Sotiria”, Athens, (2014-2019), which is the National center of excellence for rare pulmonary diseases with >2000 patients in record, participating in many international clinical trials.\n\nAs an international expert in interstitial lung diseases, he served as a Member of the ATS/ERS/JRS/ALAT committee for the idiopathic pulmonary fibrosis (IPF) official guidelines (AJRCCM 2011, AJRCCM 2018, AJRCCM 2021) guidelines; he served also as a member of the ATS/ERS new classification of idiopathic interstitial pneumonias (IIPs) (AJRCCM 2013).\n\nHis main research interests include the pathophysiologic/pathogenetic mechanisms, clinical presentation, and course of interstitial lung diseases. Among them is the investigation of experimental pharmacologic treatments for ILDs and their comorbidities, the role of the mesenchymal stem cell and extracellular vesicles application in chronic lung diseases, including pulmonary fibrosis and COPD.\n\nDr. Roberto Tonelli, MD, PhD, works as Assistant Professor in Respiratory Medicine in the Respiratory Intensive Care Unit of the University Hospital of Modena. He had training periods at the Respiratory Disease Unit of the Royal Brompton Hospital of London (UK), at the Interstitial Lung Disease Unit of the University of California San Francisco of San Francisco (CA, USA) and at the Intensive Care Unit of the Amsterdam University Medical Centers (NL)\n\nDuring his career, he has been developing skills in the management of acute respiratory failure requiring non-invasive respiratory support and mechanical ventilation. His research activities mainly focused on respiratory mechanics and patient’s self-inflicted lung injury during non-assisted and assisted spontaneous breathing in patients with acute hypoxic respiratory failure (AHRF). Moreover, he has been spending great interest in the monitoring of patients with AHRF with the aim to identify early predictors of ventilatory failure. He also explored the mechanical properties of the fibrotic lung during, controlled, assisted and non-assisted spontaneous breathing. Since 2023 he holds the patent N 102021000007478 for the “Apparatus for detecting and monitoring of nasal pressure” released by the Italian Ministry of Enterprises and Made in Italy and he is co-founder of the start-up IREC ltd. He co-founded the Experimental Pulmonology Laboratory of the University of Modena and Reggio Emilia. He is member of the European Respiratory Society and the Italian Society of Pulmonology.\n\nHe is currently involved in the design and conduction as PI and co-PI of several clinical trials exploring respiratory mechanics in patients with acute respiratory failure. Roberto Tonelli has published more than 90 peer reviewed papers and serves as associate editor, guest editor and reviewer for several major journals on respiratory diseases.\n\nDr. Stephen C. Mathai, MD, MHS is an Associate Professor of Medicine and part of the Johns Hopkins Pulmonary Hypertension Program. A graduate of Jefferson Medical College, he pursued residency training at Thomas Jefferson University Hospital, where he also served as Chief Medical Resident. During his 5-year fellowship in Pulmonary and Critical Care Medicine at Johns Hopkins University, he obtained a Masters of Health Science degree from the Johns Hopkins Bloomberg School of Public Health. Subsequently, he received a K23 award for his research in pulmonary vascular disease in scleroderma.\n\nHe currently serves as Co-Principal Investigator for the Johns Hopkins PVDOMICS program supported by the NIH and is principal investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is also the Co-Director of the Ann Dana Kusch Multidisciplinary Program for Interstitial Lung Disease and Pulmonary Hypertension.\n\nDr. Mathai is a Fellow of the American College of Chest Physicians. He has been active in numerous committees and holds several leadership positions in academic societies. He currently serves on the Scientific Secretariat for the World Symposium on Pulmonary Hypertension. Dr. Mathai is a former member of the Scientific Leadership Council of the Pulmonary Hypertension Association and also served on the Rare Disease Advisory Panel for the Patient Centered Outcomes Research Institute (PCORI). He is the past chair of the Pulmonary Vascular Disease Network for the American College of Chest Physicians. He has published over 125 original research articles, along with numerous editorials and book chapters.\n\nDr. Daines earned her doctorate at St. Louis University School of Medicine, completed her residency at Cardinal Glennon Children’s Hospital in St. Louis, and did her fellowship in pediatric pulmonary medicine at the University of North Carolina. She worked at Cincinnati Children’s Hospital Medical Center before joining The University of Arizona in 2007.\n\nDr. Daines is a Professor of Pediatrics, Division Chief Pediatric Pulmonary and Sleep Medicine, University of Arizona. She is director of the pediatric flexible bronchoscopy program and pediatric respiratory care for the Banner University Medical Center Tucson, and CF center director at the Tucson Cystic Fibrosis Care Center. She cares for children with chronic pulmonary disorders including asthma, cystic fibrosis, apnea and sleep disorders, neuromuscular diseases, airway disorders, and aerodigestive diseases. She is an expert in pediatric flexible bronchoscopy. She currently serves as President of the Pediatric Pulmonary Division Directors Association.\n\nIn addition to caring for children with pulmonary disorders, Dr. Daines conducts research through the Steele Children’s Research Center and the Asthma and Airway Diseases Research Center at the University of Arizona. She is director of the Clinical Trials Unit for the Asthma and Airway Diseases Research Center. She directs the University of Arizona’s Pediatric Pulmonary Center, a HRSA-funded training center grant to provide leadership in the care of children with complex pulmonary diseases. Her research interests include the pulmonary manifestations of gastrointestinal diseases and the impact of pulmonary aspiration on chronic lung disease. She also directs the University of Arizona’s Therapeutic Development Center for the Cystic Fibrosis Foundation and has funded clinical trial research, quality improvement research projects as well as funded adherence research projects in cystic fibrosis from the Cystic Fibrosis Foundation.\n\nDr. Daines is board certified by the American Board of Pediatrics and the American Board of Pediatric Pulmonology.\n\nDr. Christian Finley is a national leader in lung cancer management, policy, governance, standardization and benchmarking. At the Canadian Partnership Against Cancer, he has led the development of partnerships with national and provincial/territorial governments, national societies and cancer agencies to establish solution-oriented approaches to the management of complex systems of care. He is the Lung Cancer Lead at the International Benchmarking Partnership and is an advisor on lung cancer screening for the Canadian Task Force on Preventive Health Care and is the Clinical Lead for lung cancer screening in Ontario.\n\nDr. Finley is a strategic leader with extensive expertise in the Canadian and International context. He has a track record of sound analytical judgment, organizational governance, and building dynamic teams to tackle key issues. Dr. Finley co-founded and leads the national quality improvement project for Thoracic Surgery. As a thoracic surgeon at one of the busiest centres in Canada, Dr. Finley has led many initiatives that have won awards for quality and patient-centered care.\n\nRecognizing a local need, Dr. Finley conceived and fundraised for the creation of a palliative suite for patients to die with dignity.\n\nDr. Finley has received over 7 million dollars in research funding, published over 50 papers, and has been invited for over 100 national and international presentations. He has received numerous awards, including a prestigious James IV international award supporting outstanding surgical leaders to promote the exchange of knowledge around the globe. He holds a Masters degree in Public Health from Harvard University, a Doctor of Medicine from University of British Columbia and a Bachelor of Applied Science from Queen’s University. He has been an admissions interviewer for Harvard University for over 8 years.\n\nHe is the proud father of three girls and an avid outdoorsman.\n\nDavid M. Rapoport, MD, is currently Professor of Medicine Director of Sleep Research in the Division of Pulmonary, Critical Care and Sleep Medicine at the Icahn School of Medicine at Mount Sinai.\n\nDr. Rapoport received an SB in Physics at MIT and an MD at the Albert Einstein College of Medicine. He did internship and residency training in Internal Medicine at Roosevelt Hospital and Pulmonary training at Bellevue Hospital and New York University. He was on the faculty at NYU from 1980 to 2015 and established and directed the Sleep Medicine Program at NYU. In 2016 he joined the faculty of the Icahn School of Medicine at Mt. Sinai.\n\nDr. Rapoport’s research interests center around pulmonary and sleep physiology. He has spent his career studying control of breathing and of the upper airway, the epidemiology, causes, consequences and treatments of sleep disordered breathing. He is a “gadgeteer” by nature and has been involved since its origin in the development of nasal CPAP, the main treatment modality for obstructive sleep apnea. He is responsible for modifications of CPAP delivery aimed at making it more accessible and improving quality of the treatment and comfort/compliance with its use. Since the onset of the Covid-19 pandemic he has worked with Fisher and Paykel Healthcare on studying the generation and transmission of respiratory particles, both during spontaneous respiration and as a result of therapy with aerosol generating procedures like nasal high flow and CPAP/bilevel.\n\nDr. Rapoport was the New York Cohort Principle Investigator of the Sleep Heart Health Study, a large multicenter NIH sponsored epidemiologic study that assessed the cardiovascular consequences of sleep disordered breathing and of the CATNAP study, which aimed to evaluate the benefits of CPAP in mild to moderate obstructive sleep apnea. He is part of PRIDE, an NIH sponsored program that helps train and mentor minority junior faculty in preparation for careers in academic research. He is Principal Investigator or co-Principal Investigator of several industry-sponsored studies involving sleep disordered breathing and other sleep disorders. He is the founder and president of the Foundation for Research in Sleep Disorders, a non-profit that supports research and training in sleep medicine.\n\nDr. Rapoport originated and was the director of the NYU Sleep Medicine Fellowship Training Program until 2010; he has trained many clinical and research fellows in Sleep Medicine. He is a member of the American Thoracic Society, the American Physiological Society, the American Academy of Sleep Medicine and the Sleep Research Society. He is peer reviewer for multiple medical journals.\n\nDr. Rapoport is (co-)author of over 140 publications in peer-reviewed, international journals and holds 41 US Patents.\n\nDr Konstantinos Kostikas is Professor of Respiratory Medicine and Head of the Respiratory Medicine Department of the University of Ioannina, Greece, and Professor of Respiratory Medicine at the Observational and Pragmatic Research Institute, Singapore. He was trained at the University of Athens Medical School and the Royal Brompton Hospital, London, and has worked in academia and the pharmaceutical industry in global medical affairs roles.\n\nDr Kostikas is a member of GOLD COPD Assembly. He has more than 260 publications in PubMed (with >9,500 citations in Google Scholar, h-index 53), focusing on COPD, severe asthma, and new technologies. He is the Editor in Chief of Pneumon Journal (www.pneumon.org), associate editor of COPD: Journal of Chronic Obstructive Pulmonary Disease, and member of the editorial board of American Journal of Respiratory and Critical Care Medicine, PLoS One, Diagnostics and Frontiers in Medicine.\n\nPaolo Spagnolo is an Associate Professor of Respiratory Medicine and Director of the Residency Program in Respiratory Medicine at the University of Padua (Italy). He received his undergraduate training and his MD, and completed his residency in Respiratory Medicine at the University Hospital of Bari (Italy). In 2002, Dr Spagnolo joined the Interstitial Lung Disease Unit (ILDU) of the Royal Brompton Hospital (London), initially as clinical research fellow under the supervision of Professor Ron du Bois and subsequently as Honorary Consultant. In 2008, he completed his PhD at the Imperial College of London under the supervision of Professor Ron du Bois and Professor Ken Welsh, with a thesis on “Genetic predisposition to clinical phenotypes of sarcoidosis”. Between 2008 and 2013, he was a research fellow and subsequently Assistant Professor in Respiratory Medicine at the University Hospital of Modena where he joined the Centre for Rare Lung Diseases led by Professor Luca Richeldi.\n\nSince 2015, Dr Spagnolo is an Associate Professor of Respiratory Medicine at the Department of Cardiac, Thoracic, Vascular Sciences and Public Health of the University Hospital of Padua (Italy). His main research interests include ILD, mainly idiopathic pulmonary fibrosis (IPF), and sarcoidosis with emphasis on genetic predisposition, prediction of disease behaviour and clinical trials of novel therapies.\n\nDr Spagnolo is the author or co-author of over 150 journal articles, review articles and editorials. He is an Associate Editor for Chest. He is the Treasurer of the WASOG (World Association of Sarcoidosis and Other Granulomatous diseases) and Chair of the Study Group on Sarcoidosis and other Granulomatous ILD/DPLD of the European Respiratory Society. He is the chair of the European Reference Network (ERN) on rare lung diseases of the University Hospital of Padova (Italy).\n\nDr. John Goffin is a medical oncologist at the Juravinski Cancer Centre at McMaster University in Hamilton, Canada. After completing his medical oncology training at McGill University, in Montreal, he undertook fellowships at the Canadian Cancer Trials Group in Kingston and the Dana-Farber Cancer Institute in Boston. He joined Tufts New England Medical Center in Boston in 2003.\n\nIn 2006, he returned to Hamilton as a thoracic and lower gastrointestinal oncologist and clinician educator. As an educator, Dr. Goffin developed a resident research curriculum to enhance resident understanding of research and to provide research opportunities.\n\nDr. Goffin’s research interests include finding the optimal implementation and cost-effectiveness of lung cancer screening. His interest in symptom control has led him to research the relationship between chronic obstructive lung disease and outcomes in lung cancer. He conducts clinical trials to improve cancer care and has studied how those trials may be conducted more efficiently and effectively.\n\nDr. Vaidya is Professor of Medicine and Co-Director of the Pulmonary Hypertension, Right Heart Failure, and CTEPH Program at Temple University School of Medicine. Since her recruitment to Temple in 2016, they have grown to be one of the largest PH, CTEPH, PTE, and BPA programs in the United States, and she has developed an international reputation speaking and educating in Pulmonary Hypertension and CTEPH. She serves as the founding Director of Temple’s Pulmonary Hypertension Fellowship, one of only a few in the nation, and Associate Program Director of the Cardiology Fellowship and Internal Medicine Residency Program.\n\nShe is the recipient of Temple Health System’s Educational Excellence Award for Educational Service, Educational Excellence Award for Graduate Medical Education, Mentoring Award for Women in Medicine and Science, and has been recognized as a Philadelphia Top Doctor for the last 5 years. She joined Temple after serving as Co-Director of PH and APD of the Internal Medicine Residency at the University of Pennsylvania, where she received the Donna McCurdy Department of Medicine Teaching Award. She has published over 50 academic articles and book chapters, and nearly 100 abstract presentations at Medical Symposia.\n\nDr. Marcos I. Restrepo, MD, MSc, PhD, FCCP, is a Professor at the Department of Medicine, Division of Pulmonary/Critical Care Medicine, at the University of Texas Health San Antonio (UTHSA). He is an investigator and staff physician at the South Texas Veterans Health Care System, Audie L Murphy Division. He is Medical Director of the Medical Intensive Care Unit at the South Texas Veterans Health Care System, Audie L Murphy Division and the Associate Program Director of the Pulmonary/Critical Care Medicine fellowship program at UTHSA.\n\nDr. Restrepo completed training and board certifications in internal medicine, infectious disease, pulmonary disease, and critical care medicine. He obtained a Master in Science in Clinical Investigation from UTHSA and a PhD in Medicine from the Universidad de Valencia, Spain.\n\nHe has published more than 260 peer review manuscripts and presented at national and international scientific meetings. He is a member of both pneumonia (community acquired and hospital acquired) guidelines sponsored by the American Thoracic Society of America (ATS)/ and Infectious Diseases Society of America (IDSA). He serves as associate editor for European Respiratory Journal (ERJ)and Respirology"
    }
}